CN117898395B - Fermentation composition and its application in preparing products with laxative effect - Google Patents
Fermentation composition and its application in preparing products with laxative effect Download PDFInfo
- Publication number
- CN117898395B CN117898395B CN202410304132.7A CN202410304132A CN117898395B CN 117898395 B CN117898395 B CN 117898395B CN 202410304132 A CN202410304132 A CN 202410304132A CN 117898395 B CN117898395 B CN 117898395B
- Authority
- CN
- China
- Prior art keywords
- composition
- rice
- fermentation
- oatmeal
- hericium erinaceus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 238000000855 fermentation Methods 0.000 title claims abstract description 45
- 230000004151 fermentation Effects 0.000 title claims abstract description 45
- 230000002475 laxative effect Effects 0.000 title abstract description 14
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 51
- 235000009566 rice Nutrition 0.000 claims abstract description 50
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 34
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 34
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 34
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 32
- 206010010774 Constipation Diseases 0.000 claims abstract description 32
- 235000003893 Prunus dulcis var amara Nutrition 0.000 claims abstract description 32
- 241000220317 Rosa Species 0.000 claims abstract description 25
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 21
- 244000075850 Avena orientalis Species 0.000 claims abstract description 14
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000000936 intestine Anatomy 0.000 claims abstract description 12
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 9
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 7
- 235000013402 health food Nutrition 0.000 claims abstract description 6
- 235000006089 Phaseolus angularis Nutrition 0.000 claims description 29
- 240000007098 Vigna angularis Species 0.000 claims description 29
- 235000010711 Vigna angularis Nutrition 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 17
- 241000233866 Fungi Species 0.000 claims description 13
- 240000005809 Prunus persica Species 0.000 claims description 11
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 241000109329 Rosa xanthina Species 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 8
- 240000007594 Oryza sativa Species 0.000 abstract description 45
- 206010016100 Faeces discoloured Diseases 0.000 abstract description 41
- 230000000968 intestinal effect Effects 0.000 abstract description 12
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000013339 cereals Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- 239000002245 particle Substances 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 9
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000013872 defecation Effects 0.000 description 6
- 235000007558 Avena sp Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- -1 acidulants Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000008991 intestinal motility Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 229960004192 diphenoxylate Drugs 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000010716 Vigna mungo Nutrition 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229930182482 anthraquinone glycoside Natural products 0.000 description 2
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- OKTJSMMVPCPJKN-YPZZEJLDSA-N carbon-10 atom Chemical compound [10C] OKTJSMMVPCPJKN-YPZZEJLDSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229940095399 enema Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 235000010864 Armeniaca mandshurica Nutrition 0.000 description 1
- 244000147617 Armeniaca mandshurica Species 0.000 description 1
- 235000015577 Armeniaca sibirica Nutrition 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000077283 Distichlis palmeri Species 0.000 description 1
- 235000005422 Distichlis palmeri Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000032177 Intestinal Polyps Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000087211 Phaseolus calcaratus Species 0.000 description 1
- 235000012874 Phaseolus calcaratus Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 240000006066 Rosa rugosa Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000034002 defecation rhythm Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000011845 white flour Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及保健食品技术领域,尤其涉及发酵组合物及其在制备具有润肠通便的产品中的应用。本发明组合物以桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米为原料,经猴头菌发酵制得。该组合物可明显提高肠道墨汁推进率,明显缩短首粒排黑便时间,并明显增加6h排黑便粒数和6h排黑便重量,通便效果明显优于猴头菌发酵的缺方组合物2(与本发明原料相比缺少桃花和苦杏仁)、未经猴头菌发酵的组合物3(与本发明组合物相比未经发酵),说明本发明组合物中各组分具有明显增效作用,缺一不可。The present invention relates to the technical field of health food, in particular to a fermented composition and its application in preparing a product with the effect of moistening the intestine and relieving constipation. The composition of the present invention is prepared by fermenting peach blossom, rose flower, bitter almond, red bean, polished rice and oat rice with Hericium erinaceus as raw materials. The composition can significantly improve the intestinal ink propulsion rate, significantly shorten the time of the first black stool, and significantly increase the number of black stool grains discharged in 6 hours and the weight of black stool discharged in 6 hours. The laxative effect is significantly better than that of Hericium erinaceus fermented composition 2 (compared with the raw materials of the present invention, peach blossom and bitter almond are lacking) and composition 3 (compared with the composition of the present invention, no fermentation) without Hericium erinaceus fermentation, indicating that each component in the composition of the present invention has a significant synergistic effect and is indispensable.
Description
技术领域Technical Field
本发明涉及保健食品技术领域,尤其涉及发酵组合物及其在制备具有润肠通便的产品中的应用。The invention relates to the technical field of health food, in particular to a fermentation composition and application thereof in preparing a product having the function of moistening intestines and relieving constipation.
背景技术Background technique
随着社会经济的快速发展,整个社会的生活节奏逐渐加快,人们的工作压力越来越大。上班族日常饮食和作息时间极其不规律,从而导致胃肠道功能紊乱等亚健康现象越来越普遍,尤其是功能性便秘,严重影响人们的生活质量。便秘是指粪便在肠内滞留过久,排便周期延长,或周期不长,但粪质干结,排出艰难,或粪质不硬,虽有便意,但便而不畅的病证。长期干燥可伴有腹胀、口干、乏力、倦怠等症状,还可能导致痔疮、肛裂、肠道出血、息肉,严重还可引起直肠肿瘤形成。排便困难也可加重其他疾病,如高血压、急性心梗、脑血管意外等。目前西医治疗便秘主要采用的药物是外用疏导药物,多用开塞露。开塞露是高渗透压的甘油,会将肠壁内的水分渗透到肠腔内,加上甘油有润滑作用,所以可以通便。但其副作用是会造成肠壁干燥,经常使用会引起习惯性便秘。市场上治疗便秘的中药制剂常含有泻下药物大黄、番泻叶、决明子等,由于该类药物含有多种蒽醌苷类成分和鞣质类成分,蒽醌苷类成分具有泻下作用,鞣质类成分具有收敛止泻作用,因此长期服用会引起继发性便秘。同时,该类药苦寒,长期服用容易损伤脾胃导致较多的副作用,甚至引起腹泻、腹痛、肠道疾病等。因此,急需提供一种可有效改善便秘症状,不会产生依赖性且副作用小的组合物。With the rapid development of social economy, the pace of life in the whole society is gradually accelerating, and people are under increasing work pressure. The daily diet and work and rest time of office workers are extremely irregular, which leads to the increasingly common sub-health phenomena such as gastrointestinal dysfunction, especially functional constipation, which seriously affects people's quality of life. Constipation refers to the disease and syndrome of feces staying in the intestine for too long, prolonging the defecation cycle, or the cycle is not long, but the feces are dry and hard, and it is difficult to discharge, or the feces are not hard, and although there is a desire to defecate, the defecation is not smooth. Long-term dryness may be accompanied by symptoms such as abdominal distension, dry mouth, fatigue, and fatigue. It may also cause hemorrhoids, anal fissures, intestinal bleeding, polyps, and severe rectal tumors. Difficult defecation can also aggravate other diseases, such as hypertension, acute myocardial infarction, cerebrovascular accident, etc. At present, the main drugs used in Western medicine to treat constipation are external drainage drugs, and enema is often used. Enema is a high-osmotic pressure glycerin, which will penetrate the water in the intestinal wall into the intestinal cavity, and glycerin has a lubricating effect, so it can relieve constipation. However, its side effect is that it can cause dryness of the intestinal wall, and frequent use can cause habitual constipation. Traditional Chinese medicine preparations for treating constipation on the market often contain laxative drugs such as rhubarb, senna leaves, and cassia seeds. Since such drugs contain a variety of anthraquinone glycosides and tannins, anthraquinone glycosides have a laxative effect, and tannins have astringent and antidiarrheal effects, long-term use can cause secondary constipation. At the same time, such drugs are bitter and cold, and long-term use can easily damage the spleen and stomach, leading to more side effects, and even diarrhea, abdominal pain, intestinal diseases, etc. Therefore, there is an urgent need to provide a composition that can effectively improve the symptoms of constipation, does not cause dependence, and has few side effects.
发明内容Summary of the invention
有鉴于此,本发明提供了发酵组合物及其在制备具有润肠通便的产品中的应用。该发酵组合物具有显著的润肠通便功效,能够明显改善便秘症状,服用较短时间即可正常排便,不会产生依赖性,且副作用小。In view of this, the present invention provides a fermentation composition and its use in preparing a product with laxative effect. The fermentation composition has significant laxative effect, can significantly improve constipation symptoms, can defecate normally after taking it for a short time, will not cause dependence, and has little side effects.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned invention object, the present invention provides the following technical solutions:
发酵组合物,由包括桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米的原料经食用菌发酵制得。The fermented composition is prepared by fermenting raw materials including peach blossoms, rose blossoms, bitter almonds, adzuki beans, polished rice and oatmeal with edible fungi.
本发明根据中医临床治疗便秘的医理和临床经验,将具有通便作用的桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米进行组合,接入具有消化功能的猴头食用菌进行发酵,获得发酵组合物。该发酵组合物改善了肠道菌群平衡,达到了润肠通便作用。According to the medical theory and clinical experience of TCM clinical treatment of constipation, the present invention combines peach blossom, rose flower, bitter almond, red bean, polished rice and oat rice with laxative effect, and inoculates Hericium erinaceus with digestive function for fermentation to obtain a fermentation composition. The fermentation composition improves the balance of intestinal flora and achieves the effect of moistening the intestine and promoting laxative effect.
桃花,性味苦,平。具有泻下通便,利水消肿之功效。用于水肿,腹水,便秘及干燥。《圣惠方》记载用于干粪塞肠,胀痛不通。Peach blossom is bitter and flat in nature. It has the effects of purging and relieving constipation, promoting diuresis and reducing swelling. It is used for edema, ascites, constipation and dryness. "Shenghui Fang" records that it is used for dry feces blocking the intestines, distension and pain.
玫瑰花,为蔷薇科植物玫瑰Rosa rugosaThunb. 的干燥花蕾。性味甘、微苦,温。归肝、脾经。具有强肝养胃,活血调经,润肠通便,解郁安神之功效。可舒缓情绪,平衡内分泌,补血气和治疗便秘等。Rose is the dried flower bud of the plant Rosa rugosa Thunb. of the Rosaceae family. It is sweet, slightly bitter, and warm in nature. It enters the liver and spleen meridians. It has the effects of strengthening the liver and stomach, promoting blood circulation and regulating menstruation, moistening the intestines and relieving constipation, relieving depression and calming the mind. It can soothe emotions, balance endocrine, replenish blood and qi, and treat constipation.
苦杏仁,为蔷薇科植物山杏Prunus armeniaca L.var.ansu Maxim.、西伯利亚杏Prunus sibirica L.、东北杏Prunus mandshurica (Maxim.) Koehne 或杏Prunus armeniaca L. 的干燥成熟种子。有降气止咳平喘,润肠通便。用于咳嗽气喘,胸满痰多,血虚津枯,肠燥便秘。Bitter almonds are the dried mature seeds of Prunus armeniaca L.var.ansu Maxim., Prunus sibirica L., Prunus mandshurica (Maxim.) Koehne or Prunus armeniaca L. of the Rosaceae family. They have the effects of lowering qi, relieving cough and asthma, moistening the intestines and relieving constipation. They are used for cough and asthma, chest fullness and phlegm, blood deficiency and body fluid dryness, and dry intestines and constipation.
赤小豆为豆科植物赤小豆Phaseolus calcaratusRoxb. 或赤豆Phaseolus angularisWight 的干燥成熟种子。味甘,性平。能健脾利湿,散血,解毒。Adzuki bean is the dried mature seed of Phaseolus calcaratus Roxb. or Phaseolus angularis Wight of the Leguminosae family. It tastes sweet and is neutral in nature. It can invigorate the spleen and eliminate dampness, disperse blood, and detoxify.
粳米为禾本科草本植物稻(粳稻)Oryza sativaL.的种子。唐代医药学家孙思邈在《千金方·食治》中强调说,粳米能养胃气、长肌肉;清代柴裔所著《食鉴本草》也认为,粳米有补脾胃、养五脏、壮气力的良好功效。粳米味甘,性平。能益脾胃,除烦渴。现代研究证明粳米米糠层的粗纤维分子,有助胃肠蠕动,对胃病、便秘、痔疮等疗效很好;粳米能提高人体免疫功能,促进血液循环,从而减少高血压的机会。本发明中,所述粳米主要产于中国东北,又名东北大米。Japonica rice is the seed of the grass herb rice (japonica rice) Oryza sativa L. In the "Qianjin Fang·Shizhi", Sun Simiao, a medical scientist in the Tang Dynasty, emphasized that japonica rice can nourish the stomach and grow muscles; the "Shijian Bencao" written by Chai Yi in the Qing Dynasty also believed that japonica rice has good effects of nourishing the spleen and stomach, nourishing the five internal organs, and strengthening the strength. Japonica rice tastes sweet and has a neutral nature. It can benefit the spleen and stomach and eliminate thirst. Modern research has shown that the crude fiber molecules in the bran layer of japonica rice help gastrointestinal motility and have a good effect on stomach diseases, constipation, hemorrhoids, etc.; japonica rice can improve the body's immune function and promote blood circulation, thereby reducing the chance of high blood pressure. In the present invention, the japonica rice is mainly produced in Northeast China, also known as Northeast rice.
燕麦米为禾本科植物燕麦(拉丁学名:Avena sativa L.)的种子。《本草纲目》中称之为雀麦、野麦子。性味甘平。能益脾养心、敛汗。营养价值很高,燕麦中水溶性膳食纤维分别是小麦和玉米的4.7倍和7.7倍。脂肪含量是大米的4倍,其人体所需的8种氨基酸、维生素E的含量也高于大米和白面。营养学家发现,燕麦还是预防动脉粥样硬化、高血压、冠心病的理想食物。它含丰富的亚油酸,占全部不饱和脂肪酸的35%~52%,对糖尿病、脂肪肝、便秘、浮肿、心脑血管疾病等有辅助疗效,对中老年人增进体力,延年益寿大有裨益。Oat rice is the seed of the grass plant oat (Latin name: Avena sativa L.). It is called brome and wild wheat in the Compendium of Materia Medica. It is sweet and mild in nature. It can nourish the spleen and heart and stop sweating. It has high nutritional value. The water-soluble dietary fiber in oat is 4.7 times and 7.7 times that of wheat and corn respectively. The fat content is 4 times that of rice, and the content of 8 kinds of amino acids and vitamin E required by the human body is also higher than that of rice and white flour. Nutritionists have found that oat is also an ideal food for preventing atherosclerosis, hypertension and coronary heart disease. It is rich in linoleic acid, accounting for 35% to 52% of all unsaturated fatty acids. It has auxiliary therapeutic effects on diabetes, fatty liver, constipation, edema, cardiovascular and cerebrovascular diseases, etc. It is very beneficial for middle-aged and elderly people to improve their physical strength and prolong their life.
桃花、玫瑰花均含有大量的挥发油、黄酮、香豆素三叶豆苷和各种维生素等营养物质,苦杏仁含有油脂类成分,三种食药物质能够刺激胃肠蠕动,促进排便,排出身体内的毒素,通便消肿。赤小豆含有大量的蛋白质、多肽、脂肪及氨基酸类物质;粳米和燕麦米含淀粉、蛋白质、脂肪、膳食纤维,B族维生素;三种食物能益脾胃、利湿、除烦渴,预防糖尿病、脚气病、老年斑和便秘等疾病。桃花性寒,不可久服,久服会伤及脾胃;玫瑰花性温,与桃花配伍可缓和苦寒之性;赤小豆、粳米、燕麦米味甘,性平,既能益脾胃,粳米和燕麦米又能为猴头菌提供碳源和维生素,赤小豆为猴头菌提供氮源,六种药食同源物质配伍后,接入猴头菌进行生物转化,产生糖化酶可将淀粉水解为葡萄糖等营养物质,能改善肠道菌群平衡,因此组合物的发酵物花香怡人,能有效调节人体消化功能,预防和治疗顽固性便秘。Peach blossoms and roses contain a lot of volatile oils, flavonoids, coumarin trifoliate and various vitamins and other nutrients. Bitter almonds contain oil components. The three kinds of food and medicine can stimulate gastrointestinal peristalsis, promote defecation, expel toxins from the body, relieve constipation and reduce swelling. Adzuki beans contain a lot of protein, peptides, fat and amino acids; polished rice and oatmeal contain starch, protein, fat, dietary fiber and B vitamins. The three kinds of food can benefit the spleen and stomach, eliminate dampness, eliminate thirst and prevent diseases such as diabetes, beriberi, senile plaques and constipation. Peach blossom is cold in nature and should not be taken for a long time, as it will damage the spleen and stomach; rose flower is warm in nature, and can be used with peach blossom to alleviate its bitter and cold nature; adzuki bean, polished rice, and oatmeal are sweet and neutral in nature, which can benefit the spleen and stomach. Polished rice and oatmeal can also provide carbon sources and vitamins for Hericium erinaceus, and adzuki bean provides nitrogen source for Hericium erinaceus. After the six medicinal and edible substances are combined, they are connected to Hericium erinaceus for biotransformation, producing saccharifying enzymes that can hydrolyze starch into glucose and other nutrients, which can improve the balance of intestinal flora. Therefore, the fermented product of the combination has a pleasant floral fragrance, can effectively regulate the human digestive function, and prevent and treat stubborn constipation.
本发明以桃花、玫瑰花、苦杏仁、粳米、燕麦米、赤小豆为原料,利用具有健胃消食作用的食用菌(如猴头菌)进行生物转化,得到发酵组合物。小鼠连续经口灌胃给予所述发酵组合物一周后,探讨对便秘模型小鼠的润肠通便作用。结果表明,该发酵组合物具有显著的润肠通便功效,能够明显改善便秘症状,服用较短时间即可正常排便,副作用小。The present invention uses peach blossom, rose flower, bitter almond, polished rice, oat rice and red bean as raw materials, and uses edible fungi (such as Hericium erinaceus) with stomachic and digestive effects for biotransformation to obtain a fermentation composition. After mice were continuously given the fermentation composition by oral gavage for one week, the effect of moistening the intestine and relieving constipation on constipation model mice was investigated. The results showed that the fermentation composition had a significant effect of moistening the intestine and relieving constipation, could significantly improve the symptoms of constipation, and normal defecation could be achieved after taking it for a short time with little side effects.
本发明中,所述食用菌包括猴头菌。本发明对猴头菌的具体来源没有特殊限制,本领域常用的可食用的均可。在本发明的具体实施例中,猴头菌购自福芝道(吉林)生物科技有限公司。In the present invention, the edible fungi include Hericium erinaceus. The present invention has no special restrictions on the specific source of Hericium erinaceus, and any edible fungi commonly used in the art can be used. In a specific embodiment of the present invention, Hericium erinaceus is purchased from Fuzhidao (Jilin) Biotechnology Co., Ltd.
本发明中,所述粳米为浸泡后的粳米,所述燕麦米为浸泡后的燕麦米。In the present invention, the polished round-grained rice is the polished round-grained rice after soaking, and the oat rice is the oat rice after soaking.
一些实施方案中,所述桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米的干重质量比为(2~4):(2~4):(5~6):(5~6):(10~15):(68~74)。In some embodiments, the dry weight mass ratio of the peach blossom, rose flower, bitter almond, adzuki bean, polished round-grained rice and oat rice is (2-4): (2-4): (5-6): (5-6): (10-15): (68-74).
一些实施方案中,所述食用菌的添加量为所述桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米总重的10~12%,具体质量百分数可为10%、10.5%、11%、11.5%、12%。In some embodiments, the added amount of the edible fungi is 10-12% of the total weight of the peach blossoms, rose flowers, bitter almonds, red beans, polished rice and oat rice, and the specific mass percentages may be 10%, 10.5%, 11%, 11.5%, and 12%.
一些具体实施例中,所述食用菌为猴头菌,所述桃花、玫瑰花、苦杏仁、赤小豆、粳米、燕麦米和猴头菌的质量比为3:3:5:5:10:74:10。In some specific embodiments, the edible fungus is Hericium erinaceus, and the mass ratio of the peach blossom, rose flower, bitter almond, adzuki bean, polished rice, oatmeal and Hericium erinaceus is 3:3:5:5:10:74:10.
一些具体实施例中,所述食用菌为猴头菌,所述桃花、玫瑰花、苦杏仁、赤小豆、粳米、燕麦米和猴头菌的质量比为4:4:6:6:12:68:10。In some specific embodiments, the edible fungus is Hericium erinaceus, and the mass ratio of the peach blossom, rose flower, bitter almond, adzuki bean, polished rice, oatmeal and Hericium erinaceus is 4:4:6:6:12:68:10.
一些具体实施例中,所述食用菌为猴头菌,所述桃花、玫瑰花、苦杏仁、赤小豆、粳米、燕麦米和猴头菌的质量比为2:2:6:6:15:69:12。In some specific embodiments, the edible fungus is Hericium erinaceus, and the mass ratio of the peach blossom, rose flower, bitter almond, adzuki bean, polished rice, oatmeal and Hericium erinaceus is 2:2:6:6:15:69:12.
本发明还提供了所述发酵组合物的制备方法,包括:The present invention also provides a method for preparing the fermentation composition, comprising:
将桃花、玫瑰花、苦杏仁和赤小豆粉碎后,与浸泡后的粳米和燕麦米混合,灭菌,冷却至室温接种猴头菌后进行发酵培养;Peach blossoms, roses, bitter almonds and adzuki beans are crushed, mixed with soaked polished rice and oatmeal, sterilized, cooled to room temperature, inoculated with Hericium erinaceus and fermented;
收集发酵产物,干燥、粉碎,获得本发明发酵组合物。The fermentation product is collected, dried and crushed to obtain the fermentation composition of the present invention.
一些实施方案中,所述浸泡为用水浸泡,所述浸泡至用手轻轻碾碎的程度;In some embodiments, the soaking is soaking in water, and the soaking is to the extent of being lightly crushed by hand;
所述发酵培养的温度为28℃-32℃,培养至长满菌丝,一般培养时间为20~30d。The fermentation culture temperature is 28° C.-32° C., and the culture is carried out until the mycelium is fully grown. The general culture time is 20-30 days.
一些实施方案中,所述干燥的温度为50℃~75℃,具体可为50℃、55℃、60℃、65℃、70℃、75℃。In some embodiments, the drying temperature is 50°C to 75°C, specifically 50°C, 55°C, 60°C, 65°C, 70°C, or 75°C.
本发明还提供了所述发酵组合物或本发明所述制备方法制得的发酵组合物在制备具有润肠通便的产品中的应用。The present invention also provides the use of the fermentation composition or the fermentation composition prepared by the preparation method of the present invention in preparing a product having the effect of moistening the intestine and relieving constipation.
本发明还提供一种保健食品,包括有效量的本发明所述发酵组合物和食品学上可接受的辅料。The present invention also provides a health food, comprising an effective amount of the fermentation composition of the present invention and auxiliary materials acceptable in food science.
本发明对食品学上可接受的辅料没有特殊要求,本领域常见的或常用的种类均可,如食用香精、甜味剂、酸味剂、填充剂、防腐剂等,本领域技术人员可根据实际需求进行添加。The present invention has no special requirements for excipients acceptable in food science, and any common or commonly used types in the art can be used, such as edible flavors, sweeteners, acidulants, fillers, preservatives, etc. Those skilled in the art can add them according to actual needs.
所述保健食品可以为当前保健品领域任何剂型,包括但不仅限于丸剂、胶囊剂、片剂、粉剂、颗粒剂、口服液或膏剂等。The health food can be in any dosage form in the current health care product field, including but not limited to pills, capsules, tablets, powders, granules, oral liquids or pastes, etc.
各剂型可根据该剂型实际需要选取合适的可接受辅料来制备,这属于本领域常规的剂型制备技术。Each dosage form can be prepared by selecting suitable acceptable excipients according to the actual needs of the dosage form, which belongs to the conventional dosage form preparation technology in the field.
本发明以桃花、玫瑰花、苦杏仁、粳米、燕麦米、赤小豆为原料,利用具有健胃消食作用的食用菌(如猴头菌)进行生物转化,得到发酵组合物。该发酵组合物健康营养,具有一定保健作用,可通过食疗缓解便秘,安全有效,改善人们的亚健康状态,适合大众食用。The present invention uses peach blossom, rose flower, bitter almond, polished rice, oat rice and red bean as raw materials, and uses edible fungi (such as Hericium erinaceus) with stomachic and digestive effects for biotransformation to obtain a fermentation composition. The fermentation composition is healthy and nutritious, has certain health care effects, can relieve constipation through diet therapy, is safe and effective, improves people's sub-health status, and is suitable for public consumption.
具体实施方式Detailed ways
本发明提供了发酵组合物及其在制备具有润肠通便的产品中的应用。本领域技术人员可以借鉴本文内容,适当改进工艺参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明的方法及应用已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文的方法和应用进行改动或适当变更与组合,来实现和应用本发明技术。The present invention provides a fermentation composition and its application in the preparation of a product with laxative effect. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the method and application of this article without departing from the content, spirit and scope of the present invention to realize and apply the technology of the present invention.
本发明采用的原料皆为普通市售品,皆可于市场购得。The raw materials used in the present invention are all common commercial products and can be purchased in the market.
下面结合实施例,进一步阐述本发明:The present invention will be further described below in conjunction with embodiments:
实施例1 发酵组合物的制备Example 1 Preparation of fermentation composition
对桃花、玫瑰花、苦杏仁、赤小豆进行筛选,并用水清洗表面污垢等杂质,干燥,粉碎成粗粉。精挑选优质的东北大米和燕麦米一起用水淘洗干净,浸泡至用手轻轻碾碎的程度。将桃花:玫瑰花:苦杏仁:赤小豆:粳米:燕麦米按照干重质量比为3:3:5:5:10:74的比例混合,在121℃下灭菌50 min。冷却到室温之后加入10%猴头菌菌种。将混合好的原材料放入无菌的容器中,密封。置于28℃恒温发酵培养至菌丝长满,收集发酵产物,60℃干燥,粉碎,获得发酵组合物。Peach blossoms, roses, bitter almonds, and adzuki beans were screened, and the surface dirt and other impurities were washed with water, dried, and crushed into coarse powder. Carefully selected high-quality Northeastern rice and oatmeal were washed with water and soaked until they could be gently crushed by hand. Peach blossoms: roses: bitter almonds: adzuki beans: polished rice: oatmeal were mixed in a dry weight ratio of 3:3:5:5:10:74 and sterilized at 121°C for 50 min. After cooling to room temperature, 10% Hericium erinaceus strains were added. The mixed raw materials were placed in a sterile container and sealed. Fermented and cultured at a constant temperature of 28°C until the mycelium was fully grown, the fermentation products were collected, dried at 60°C, and crushed to obtain a fermentation composition.
实施例2 发酵组合物的制备Example 2 Preparation of fermentation composition
对桃花、玫瑰花、苦杏仁、赤小豆进行筛选,并用水清洗表面污垢等杂质,干燥,粉碎成粗粉。精挑选优质的东北大米和燕麦米一起用水淘洗干净,浸泡至用手轻轻碾碎的程度。将桃花:玫瑰花:苦杏仁:赤小豆:粳米:燕麦米按照干重质量比为4:4:6:6:12:68的比例混合,在126℃下灭菌40 min。冷却到室温之后加入10%猴头菌菌种。将混合好的原材料放入无菌的容器中,密封。置于30℃恒温发酵培养至菌丝长满,收集发酵产物,70℃干燥,粉碎,获得发酵组合物。Peach blossoms, roses, bitter almonds, and adzuki beans were screened, and the surface dirt and other impurities were washed with water, dried, and crushed into coarse powder. Carefully selected high-quality Northeastern rice and oatmeal were washed with water and soaked until they could be gently crushed by hand. Peach blossoms: roses: bitter almonds: adzuki beans: polished rice: oatmeal were mixed in a dry weight ratio of 4:4:6:6:12:68 and sterilized at 126°C for 40 min. After cooling to room temperature, 10% Hericium erinaceus strains were added. The mixed raw materials were placed in a sterile container and sealed. Fermented and cultured at a constant temperature of 30°C until the mycelium was fully grown, the fermentation products were collected, dried at 70°C, and crushed to obtain a fermentation composition.
实施例3 发酵组合物的制备Example 3 Preparation of fermentation composition
对桃花、玫瑰花、苦杏仁、赤小豆进行筛选,并用水清洗表面污垢等杂质,干燥,粉碎成粗粉。精挑选优质的东北大米和燕麦米一起用水淘洗干净,浸泡至用手轻轻碾碎的程度。将桃花:玫瑰花:苦杏仁:赤小豆:粳米:燕麦米按照干重质量比为2:2:6:6:15:69的比例混合,在126℃下灭菌30 min。冷却到室温之后加入12%猴头菌菌种。将混合好的原材料放入无菌的容器中,密封。置于32℃恒温发酵培养至菌丝长满,收集发酵产物,75℃干燥,粉碎,获得发酵组合物。Peach blossoms, roses, bitter almonds, and adzuki beans were screened, and the surface dirt and other impurities were washed with water, dried, and crushed into coarse powder. Carefully selected high-quality Northeastern rice and oatmeal were washed with water and soaked until they could be gently crushed by hand. Peach blossoms: roses: bitter almonds: adzuki beans: polished rice: oatmeal were mixed in a dry weight ratio of 2:2:6:6:15:69 and sterilized at 126°C for 30 min. After cooling to room temperature, 12% Hericium erinaceus strains were added. The mixed raw materials were placed in a sterile container and sealed. Fermented and cultured at a constant temperature of 32°C until the mycelium was fully grown, the fermentation product was collected, dried at 75°C, and crushed to obtain a fermentation composition.
试验例1、组合物对小鼠小肠运动实验Test Example 1: Effect of the composition on small intestinal motility in mice
1 方法1 Methods
1.1 组合物及其制备1.1 Composition and preparation
组合物1的制备:按照实施例1的方法制备发酵组合物,得组合物1。Preparation of Composition 1: A fermentation composition was prepared according to the method of Example 1 to obtain Composition 1.
组合物2的制备:取玫瑰花、赤小豆、粳米和燕麦米,按玫瑰花:赤小豆:粳米:燕麦米干重质量比为3:5:10:74的比例混合,在121℃下灭菌50 min,冷却到室温之后加入10%猴头菌菌种,将混合好的原材料放入无菌的容器中,密封,置于28℃恒温培养至菌丝长满,收集发酵产物,60℃干燥,粉碎,得组合物2。其中猴头菌菌种与实施例1中的相同。Preparation of composition 2: Rose, adzuki bean, polished rice and oatmeal are mixed in a dry weight mass ratio of rose: adzuki bean: polished rice: oatmeal of 3:5:10:74, sterilized at 121°C for 50 min, and added with 10% Hericium erinaceus strain after cooling to room temperature, and the mixed raw materials are placed in a sterile container, sealed, and cultured at a constant temperature of 28°C until the mycelium is fully grown, and the fermentation product is collected, dried at 60°C, and crushed to obtain composition 2. The Hericium erinaceus strain is the same as that in Example 1.
组合物3的制备:取桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米,按桃花:玫瑰花:苦杏仁:赤小豆:粳米:燕麦米质量比为3:3:5:5:10:74的比例混合,粉碎,得组合物3。Preparation of composition 3: Take peach blossom, rose, bitter almond, adzuki bean, polished rice and oatmeal, mix them in a mass ratio of 3:3:5:5:10:74 of peach blossom: rose: bitter almond: adzuki bean: polished rice: oatmeal, and grind them to obtain composition 3.
1.2 小肠运动实验1.2 Small intestinal motility test
根据《保健食品功能学检验与技术评价规范》(2003版)通便功能检验方法。小鼠分5组,每组6只,分为空白对照组、模型对照组,HF1组(组合物1,3.32g/kgBW)、HF2组(组合物2,3.32g/kgBW)、ZH组(组合物3,3.32/kgBW)(相当于人每日用量的10 倍)3个给药组。每日以蒸馏水配置不同浓度样品,以20mL/kgBW灌胃给予动物,空白对照组和模型对照组给同体积蒸馏水。连续给予受试样品7天。给受试样品7天后,各组小鼠禁食不禁水16小时。模型对照组和三个给药组灌胃给予复方地芬诺酯5mg/kgBW(10mL/kgBW),空白对照组给蒸馏水。给予复方地芬诺酯0.5小时后,各给药组分别灌胃给予含相应受试样品的墨汁(含5%的活性炭粉、10%阿拉伯树胶),空白对照组和模型对照组给予墨汁。25分钟后立即脱颈椎处死动物,打开腹腔分离肠系膜,剪取上端自幽门、下端至回盲部的肠管,置于托盘上,轻轻将小肠拉成直线,测量肠管长度为“小肠总长度”,从幽门至墨汁前沿为“墨汁推进长度”,按下式计算墨汁推进率:According to the laxative function test method of the "Health Food Functional Test and Technical Evaluation Specification" (2003 Edition). The mice were divided into 5 groups, 6 in each group, and divided into 3 dosing groups: blank control group, model control group, HF1 group (composition 1, 3.32g/kgBW), HF2 group (composition 2, 3.32g/kgBW), and ZH group (composition 3, 3.32/kgBW) (equivalent to 10 times the daily dose of humans). Different concentrations of samples were prepared with distilled water every day, and the animals were gavaged at 20mL/kgBW. The blank control group and the model control group were given the same volume of distilled water. The test samples were given continuously for 7 days. After 7 days of giving the test samples, the mice in each group were fasted but not watered for 16 hours. The model control group and the three dosing groups were gavaged with compound diphenoxylate 5mg/kgBW (10mL/kgBW), and the blank control group was given distilled water. 0.5 hours after the administration of compound diphenoxylate, each administration group was gavaged with ink (containing 5% activated carbon powder and 10% gum arabic) containing the corresponding test sample, and the blank control group and the model control group were given ink. 25 minutes later, the animals were immediately killed by dislocating the cervical vertebra, the abdominal cavity was opened to separate the mesentery, and the intestinal tube from the pylorus at the upper end and the ileocecal part at the lower end was cut and placed on a tray. The small intestine was gently pulled into a straight line, and the intestinal length was measured as the "total length of the small intestine", and the length from the pylorus to the front of the ink was the "ink advancement length". The ink advancement rate was calculated according to the following formula:
1.3 统计方法1.3 Statistical methods
采用SPSS18.0软件进行统计分析,计量数据结果以表示,多组之间采用单因素方差分析比较,组间比较采用t检验。以P<0.05为差异有统计学意义。SPSS 18.0 software was used for statistical analysis. The differences were statistically significant when P < 0.05.
1.4 结果判定1.4 Result determination
在模型成立的前提下,受试样品组小鼠的墨汁推进率显著高于模型对照组的墨汁推进率时,可判定该项实验结果为阳性。On the premise that the model is established, when the ink propagation rate of the mice in the test sample group is significantly higher than that in the model control group, the experimental result can be determined to be positive.
2 结果2 Results
由表1可见,相比空白对照组,模型对照组的墨汁推进长度明显缩短,墨汁推进率显著降低(P<0.05),表明小肠蠕动抑制模型成立;与模型对照组比较,受试样品各给药组墨汁推进长度、推进率增加,其中,HF1组的墨汁推进率与模型对照组具有极显著差异(P<0.01),HF2组的墨汁推进率与模型对照组具有显著差异(P<0.05),而ZH组的墨汁推进率和墨汁推进长度与模型对照组相比均无明显差异(P>0.05)。根据结果判定标准,判定小肠运动实验结果阳性。As shown in Table 1, compared with the blank control group, the ink propulsion length of the model control group was significantly shortened, and the ink propulsion rate was significantly reduced (P<0.05), indicating that the small intestinal peristalsis inhibition model was established; compared with the model control group, the ink propulsion length and propulsion rate of each drug-treated group of the test sample increased, among which the ink propulsion rate of the HF1 group was extremely significantly different from that of the model control group (P<0.01), and the ink propulsion rate of the HF2 group was significantly different from that of the model control group (P<0.05), while the ink propulsion rate and ink propulsion length of the ZH group were not significantly different from those of the model control group (P>0.05). According to the result judgment criteria, the small intestinal motility test results were judged to be positive.
表1:组合物对小肠运动的影响Table 1: Effects of the composition on small intestinal motility
注:与空白组比较,#为差异显著P<0.05,##为差异极显著P<0.01。Note: Compared with the blank group, # indicates significant difference P<0.05, ## indicates extremely significant difference P<0.01.
与模型组比较,*为差异显著P<0.05;**为差异极显著P<0.01。Compared with the model group, * indicates significant difference, P<0.05; ** indicates extremely significant difference, P<0.01.
3 结论3 Conclusion
HF1组、HF2组和ZH组三个给药组每天灌胃给予小鼠一次,灌胃体积20mL/kgBW,空白对照组和模型对照组给同体积蒸馏水,连续给予7天。在本实验条件下,小肠运动实验的结果为阳性。The mice were given oral administration once a day in the three drug-dosing groups: HF1, HF2 and ZH, with an oral administration volume of 20 mL/kg BW. The blank control group and the model control group were given the same volume of distilled water for 7 consecutive days. Under the experimental conditions, the results of the small intestinal motility test were positive.
墨汁推进率越高,通便效果越好。相比模型组,HF1组和HF2组的墨汁推进率都有显著提高,其中,HF1组与模型组具有极显著性差异(P<0.01),HF2组与模型组具有显著性差异(P<0.05)。而ZH组与模型组无显著差异(P>0.05)。结果表明,HF1组的通便效果明显优于HF2和ZH组。The higher the ink propulsion rate, the better the laxative effect. Compared with the model group, the ink propulsion rates of the HF1 group and the HF2 group were significantly increased, among which the HF1 group had a very significant difference with the model group (P<0.01), and the HF2 group had a significant difference with the model group (P<0.05). However, there was no significant difference between the ZH group and the model group (P>0.05). The results showed that the laxative effect of the HF1 group was significantly better than that of the HF2 and ZH groups.
试验例2、组合物对小鼠排便时间、黑便粒数和黑便重量的测量Test Example 2: Effect of the composition on the defecation time, number of black stool particles and weight of black stool in mice
1 方法1 Methods
1.1 组合物的制备1.1 Preparation of composition
组合物1的制备:按照实施例1的方法制备,获得组合物1。Preparation of composition 1: Composition 1 was obtained by the method of Example 1.
组合物2的制备:取玫瑰花、赤小豆、粳米和燕麦米,按玫瑰花:赤小豆:粳米:燕麦米干重质量比为3:5:10:74的比例混合,在121℃下灭菌50 min,冷却到室温之后加入10%猴头菌菌种,将混合好的原材料放入无菌的容器中,密封,置于28℃恒温培养至菌丝长满,收集发酵产物,60℃干燥,粉碎,得组合物2。其中猴头菌菌种与实施例1中的相同。Preparation of composition 2: Rose, adzuki bean, polished rice and oatmeal are mixed in a dry weight mass ratio of rose: adzuki bean: polished rice: oatmeal of 3:5:10:74, sterilized at 121°C for 50 min, and added with 10% Hericium erinaceus strain after cooling to room temperature, and the mixed raw materials are placed in a sterile container, sealed, and cultured at a constant temperature of 28°C until the mycelium is fully grown, and the fermentation product is collected, dried at 60°C, and crushed to obtain composition 2. The Hericium erinaceus strain is the same as that in Example 1.
组合物3的制备:取桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米,按桃花:玫瑰花:苦杏仁:赤小豆:粳米:燕麦米质量比为3:3:5:5:10:74的比例混合,粉碎,得组合物3。Preparation of composition 3: Take peach blossom, rose, bitter almond, adzuki bean, polished rice and oatmeal, mix them in a mass ratio of 3:3:5:5:10:74 of peach blossom: rose: bitter almond: adzuki bean: polished rice: oatmeal, and grind them to obtain composition 3.
1.2 排便时间、黑便粒数和黑便重量的测量1.2 Measurement of defecation time, number of black stool particles, and weight of black stool
小鼠分5组,每组6只,分为空白对照组、模型对照组,HF1组(组合物1,3.32g/kgBW)、HF2组(组合物2,3.32g/kgBW)、ZH组(组合物3,3.32/kgBW)(相当于人每日用量的10倍)3个给药组。每日以蒸馏水配制不同浓度样品,以20mL/kgBW灌胃给予动物,空白对照组和模型对照组给同体积蒸馏水。连续给予受试样品7天。给受试样品7天后,各组小鼠禁食不禁水16小时,空白对照组给蒸馏水,模型对照组和三个给药组灌胃给予复方地芬诺酯10mg/kgBW(10mL/kgBW)。给予复方地芬诺酯0.5h后,各给药组分别灌胃给予含相应受试样品的墨汁(含5%的活性炭粉、10%阿拉伯树胶),空白对照组和模型对照组给予墨汁,动物均单笼饲养,正常饮水进食。从灌墨汁开始,记录每只动物首粒排黑便时间、6h内排黑便粒数及重量。The mice were divided into 5 groups, 6 mice in each group, and divided into 3 dosing groups: blank control group, model control group, HF1 group (composition 1, 3.32g/kgBW), HF2 group (composition 2, 3.32g/kgBW), and ZH group (composition 3, 3.32/kgBW) (equivalent to 10 times the daily dose of humans). Different concentrations of samples were prepared with distilled water every day and administered to animals by gavage at 20mL/kgBW. The blank control group and the model control group were given the same volume of distilled water. The test samples were administered continuously for 7 days. After 7 days of administration of the test samples, the mice in each group were fasted but not watered for 16 hours. The blank control group was given distilled water, and the model control group and the three dosing groups were given compound diphenoxylate 10mg/kgBW (10mL/kgBW) by gavage. 0.5h after compound diphenoxylate was administered, each administration group was gavaged with ink (containing 5% activated carbon powder and 10% gum arabic) containing the corresponding test sample, and the blank control group and model control group were given ink. The animals were housed in single cages and fed with normal water. From the beginning of ink administration, the time of the first black stool of each animal, the number of black stools within 6h and the weight were recorded.
1.3 统计方法1.3 Statistical methods
采用SPSS18.0软件进行统计分析,计量数据结果以表示,多组之间采用单因素方差分析比较,组间比较采用t检验。以P<0.05为差异有统计学意义。SPSS 18.0 software was used for statistical analysis. The differences were statistically significant when P < 0.05.
1.4 结果判定1.4 Result determination
在小肠便秘模型成立的前提下,受试样品组小鼠的首粒排黑便时间明显短于模型对照组,即可判定该项指标结果为阳性。6小时内排黑便粒数明显高于模型对照组,可判定该项指标结果为阳性。6小时内排黑便重量明显高于模型对照组,可判定该项指标结果为阳性。Under the premise of establishing the small intestinal constipation model, if the time of the first black stool of the mice in the test sample group is significantly shorter than that of the model control group, the result of this indicator can be determined to be positive. If the number of black stools discharged within 6 hours is significantly higher than that of the model control group, the result of this indicator can be determined to be positive. If the weight of black stools discharged within 6 hours is significantly higher than that of the model control group, the result of this indicator can be determined to be positive.
2 结果2 Results
由表2可见,与空白对照组比较,模型对照组首粒排黑便时间显著延长(P<0.05),排黑便粒数和重量均极显著地降低(P<0.01),表明小肠便秘模型成立。与模型对照组比较,各给药组均能明显缩短首粒排黑便时间、增加6h内排黑便粒数和重量。其中,HF1组的首粒排黑便时间、6h内排黑便粒数和重量与模型对照组相比均存在显著性差异(P<0.01),HF2组的6h内排黑便粒数和重量与模型对照组相比具有显著性差异(P<0.05),而ZH组仅首粒排黑便时间与模型对照组相比具有显著性差异(P<0.05)。根据结果判定标准,判定首粒排黑便时间、排黑便粒数和排黑便重量这三项指标的结果均为阳性。As shown in Table 2, compared with the blank control group, the time of the first black stool in the model control group was significantly prolonged (P<0.05), and the number and weight of black stool particles were extremely significantly reduced (P<0.01), indicating that the small intestinal constipation model was established. Compared with the model control group, each drug-treated group could significantly shorten the time of the first black stool and increase the number and weight of black stool particles within 6 hours. Among them, the time of the first black stool, the number and weight of black stool particles within 6 hours in the HF1 group were significantly different from those in the model control group (P<0.01), the number and weight of black stool particles within 6 hours in the HF2 group were significantly different from those in the model control group (P<0.05), and only the time of the first black stool in the ZH group was significantly different from that in the model control group (P<0.05). According to the result judgment criteria, the results of the three indicators of the time of the first black stool, the number of black stool particles and the weight of black stool were all positive.
表2:组合物对首粒排黑便时间、黑便粒数和黑便重量的影响()Table 2: Effects of the composition on the time to first black stool, number of black stools and weight of black stools ( )
注:与空白组比较,#为差异显著P<0.05,##为差异极显著P<0.01。Note: Compared with the blank group, # indicates significant difference P<0.05, ## indicates extremely significant difference P<0.01.
与模型组比较,*为差异显著P<0.05;**为差异极显著P<0.01。Compared with the model group, * indicates significant difference, P<0.05; ** indicates extremely significant difference, P<0.01.
3 结论3 Conclusion
组合物HF1组、HF2组、ZH组三个给药组每天灌胃给予小鼠一次,灌胃体积20mL/kgBW,空白对照组和模型对照组给同体积蒸馏水,连续给予7天。在本实验条件下,首粒排黑便时间这项指标的结果为阳性;排黑便粒数的这项指标的结果为阳性;排黑便重量这项指标的结果为阳性。The three groups of HF1, HF2 and ZH were given to mice by gavage once a day, with a gavage volume of 20 mL/kg BW, and the blank control group and the model control group were given the same volume of distilled water for 7 consecutive days. Under the experimental conditions, the result of the first black stool time was positive; the result of the number of black stools was positive; the result of the weight of black stools was positive.
由表2可知,本发明组合物1(HF1组)可以明显缩短首粒排黑便时间,并明显增加6h排黑便粒数和6h排黑便重量,与模型组相比均具有极显著差异(P<0.01)。而猴头菌发酵缺少桃花和苦杏仁的组合物2(HF1组)与模型组相比,仅6h排黑便粒数和6h排黑便重量显著增加(P<0.05),首粒排黑便时间无显著差异(P>0.05)。组合物3(ZH组)与模型组相比,首粒排黑便时间可显著缩短(P<0.05),6h排黑便粒数和6h排黑便重量虽有改善但均无显著差异(P>0.05)。说明,本发明组合物1的通便效果明显优于组合物2和3。As shown in Table 2, the composition 1 (HF1 group) of the present invention can significantly shorten the time of the first black stool, and significantly increase the number of black stool particles and the weight of black stool particles in 6 hours, which are significantly different from the model group (P<0.01). However, the composition 2 (HF1 group) fermented by Hericium erinaceus lacking peach blossom and bitter almonds, compared with the model group, only the number of black stool particles and the weight of black stool particles in 6 hours were significantly increased (P<0.05), and there was no significant difference in the time of the first black stool (P>0.05). Compared with the model group, the composition 3 (ZH group) can significantly shorten the time of the first black stool (P<0.05), and the number of black stool particles and the weight of black stool particles in 6 hours are improved, but there is no significant difference (P>0.05). It shows that the laxative effect of the composition 1 of the present invention is significantly better than that of the compositions 2 and 3.
由以上结果可知,本发明以桃花、玫瑰花、苦杏仁、赤小豆、粳米和燕麦米为原料,经猴头菌发酵制得的组合物,可明显提高肠道墨汁推进率,明显缩短首粒排黑便时间,并明显增加6h排黑便粒数和6h排黑便重量。表明,本发明组合物的通便效果明显优于猴头菌发酵的缺方组合物2(与本发明原料相比缺少桃花和苦杏仁)、未经猴头菌发酵的组合物3(与本发明组合物相比未经发酵),说明,本发明组合物中各组分配伍合理,产生了良好的增效作用,缺一不可。From the above results, it can be seen that the composition of the present invention, which is prepared by fermenting peach blossom, rose flower, bitter almond, red bean, polished rice and oatmeal with Hericium erinaceus, can significantly improve the intestinal ink propulsion rate, significantly shorten the time of the first black stool, and significantly increase the number of black stools discharged in 6 hours and the weight of black stools discharged in 6 hours. It shows that the laxative effect of the composition of the present invention is significantly better than that of Hericium erinaceus fermented composition 2 (compared with the raw materials of the present invention, peach blossom and bitter almond are lacking) and composition 3 (compared with the composition of the present invention, no fermentation) without Hericium erinaceus fermentation, indicating that the components in the composition of the present invention are reasonably matched and produce a good synergistic effect, and none of them is indispensable.
以上仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only preferred embodiments of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410304132.7A CN117898395B (en) | 2024-03-18 | 2024-03-18 | Fermentation composition and its application in preparing products with laxative effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410304132.7A CN117898395B (en) | 2024-03-18 | 2024-03-18 | Fermentation composition and its application in preparing products with laxative effect |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117898395A CN117898395A (en) | 2024-04-19 |
CN117898395B true CN117898395B (en) | 2024-06-21 |
Family
ID=90692565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410304132.7A Active CN117898395B (en) | 2024-03-18 | 2024-03-18 | Fermentation composition and its application in preparing products with laxative effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117898395B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108042667A (en) * | 2017-12-27 | 2018-05-18 | 重庆六脉堂生物科技有限公司 | It is a kind of to promote human qi and blood running and the seven flower cream by scattered silt knot and preparation method thereof |
CN108740742A (en) * | 2018-05-22 | 2018-11-06 | 河南中立生物科技有限公司 | A kind of five-element support lung and decompose congee and preparation method thereof |
CN109170544A (en) * | 2018-10-16 | 2019-01-11 | 汉中三道中瑞生态农业科技有限公司 | A kind of preparation method and applications of hericium erinaceus grain powder |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100336649B1 (en) * | 2000-12-26 | 2002-05-16 | 강창환 | The composites of fermented vegetable drinks possessing the function of cleaning the bowels and relieving constipation |
KR101847280B1 (en) * | 2016-08-12 | 2018-04-10 | 이현선 | Hericium erinaceum natural yeast fermenting method and powder thereof |
CN108294298A (en) * | 2017-08-22 | 2018-07-20 | 湖北省农业科学院农产品加工与核农技术研究所 | A method of preparing nutritional meal replacement powder using bacteria solid fermentation mycoplasma is eaten |
CN107854548B (en) * | 2017-11-20 | 2020-07-31 | 湖南汉森制药股份有限公司 | Composition with bowel relaxing function |
KR102077708B1 (en) * | 2018-03-28 | 2020-02-14 | 재단법인 장흥군버섯산업연구원 | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component |
CN110432428A (en) * | 2019-08-29 | 2019-11-12 | 湖北亚菌园生物科技有限公司 | Black coarse cereal powder of a kind of Hericium erinaceus five and preparation method thereof |
CN115316667A (en) * | 2022-08-12 | 2022-11-11 | 长春中医药大学 | A kind of health food composition that is helpful for moistening bowel and laxative and preparation method thereof |
KR102623946B1 (en) * | 2023-02-14 | 2024-01-15 | 조민준 | Method for producing gruel and soup using mushroom fermented soybean |
CN116211938A (en) * | 2023-03-06 | 2023-06-06 | 无锡康能特医食品科技有限公司 | Lentinus edodes strain fermentation composition and preparation method and application thereof |
-
2024
- 2024-03-18 CN CN202410304132.7A patent/CN117898395B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108042667A (en) * | 2017-12-27 | 2018-05-18 | 重庆六脉堂生物科技有限公司 | It is a kind of to promote human qi and blood running and the seven flower cream by scattered silt knot and preparation method thereof |
CN108740742A (en) * | 2018-05-22 | 2018-11-06 | 河南中立生物科技有限公司 | A kind of five-element support lung and decompose congee and preparation method thereof |
CN109170544A (en) * | 2018-10-16 | 2019-01-11 | 汉中三道中瑞生态农业科技有限公司 | A kind of preparation method and applications of hericium erinaceus grain powder |
Non-Patent Citations (1)
Title |
---|
猴头菌固体发酵技术及其对发酵产物中生物活性物质影响研究进展;李昕阳,等,;《中国酿造》;20231225;第42卷(第12期);第28-32页 * |
Also Published As
Publication number | Publication date |
---|---|
CN117898395A (en) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103141709B (en) | Carp feed and preparation method thereof | |
CN101518580B (en) | Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof | |
CN112568324B (en) | Composite probiotics fermented traditional Chinese medicine feed additive and preparation method and application thereof | |
CN108094792A (en) | A kind of probiotics fermention functional food for improving male's inferior health and preparation method thereof | |
KR101883154B1 (en) | Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it | |
CN107279923A (en) | ginseng composite fermentation nutrient powder and preparation method thereof | |
KR101826737B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
WO2021008265A1 (en) | Anti-aging soft capsule for menopausal women and preparation method therefor | |
KR20200058326A (en) | Carob fruit composition and its manufacturing method and use | |
CN117898395B (en) | Fermentation composition and its application in preparing products with laxative effect | |
CN115969909B (en) | Traditional Chinese medicine composition and fermented traditional Chinese medicine preparation for improving sub-health of sow as well as preparation method and application of traditional Chinese medicine composition and fermented traditional Chinese medicine preparation | |
CN110613793A (en) | Anti-tumor composition and preparation method and application thereof | |
CN105232959B (en) | A Chinese medicinal composition | |
KR102165106B1 (en) | A pill or granule comprising Dendropanax Morbifera extract for improving constipation disease and a method for producing the same. | |
CN114432376A (en) | Blood fat regulating pharmaceutical composition and preparation thereof | |
CN109566951B (en) | Stomach-protecting chewable tablet containing radix astragali or stem, leaf and flower of radix astragali | |
CN1491671A (en) | A Chinese medicinal composition for treating hepatocarcinoma and pancreatic cancer, and its preparation method | |
JPH11158077A (en) | Composition having alleviating effect on stress | |
CN1328968C (en) | Intermediate peashrub flower health tea | |
CN118680986B (en) | Composition capable of preventing and assisting in treating type II diabetes and preparation method and application thereof | |
CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
KR102439636B1 (en) | Composition for alleviating muscle tics and depression and manufacturing method thereof | |
CN108432968A (en) | A kind of feed addictive and preparation method thereof for improving beaver rabbit fur quality | |
CN102166300B (en) | Traditional Chinese medicine preparation for treating lung yin deficiency, stomach yin deficiency and diabetes yin deficiency symptoms | |
CN110507713A (en) | A kind of Chinese medicine composition with antidepressant effect, food and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |